Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma

Overview of attention for article published in Multidisciplinary Respiratory Medicine, June 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Article in Multidisciplinary Respiratory Medicine (June 2018)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma

Article in Therapeutic Advances in Respiratory Disease (January 2018)

Fluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EU

Article in Drugs & Therapy Perspectives (March 2017)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.